To confirm that CACNA2D1 is specifically expressed in the NPC tumour cells, we clinically examined the expression level of CACNA2D1 using GeoMx digital spatial profiling (DSP). This evidence concerns the gene CACNA2D1 and nasopharyngeal carcinoma.